Yield10 Bioscience (YTEN) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Agriculture Air Biodegradable Biodiesel Biofuel Biomass Carbon Carbon Capture Carbon Emissions Carbon Footprint Clean Climate Climate Change Ecological Environment Environmental Escape Extraction Fisheries Forest Greenhouse Greenhouse Gas Greenhouse Gas Emission Intensity Life Cycle Materials Natural Resources Nature Ocean Offset Oil Package Packaging Pandemic Petroleum Plastic Pollution Recycled Renewable Scarce Soil Waste Wastewater Water Wind Access African American Asian Benefits Black Collective Bargaining Community Consumer Sentiment Customer Cyber Cybersecurity Death Disability Diversity Employee Engagement Ethnicity Gender Health and Safety Healthcare Hire Hiring Hispanic Human Capital Incident Injury Latinx LGBTQ Pay for Performance Recall Recruit Reimbursement Retention Safety Satisfaction Skill Skilled Skills Social Society Supplier Supply Chain Talent Training Union Workforce Action Plan Assessment Assurance Audit Bonus Classified Commitment Conflict of Interest Corporate Governance Department of Ethics Executive Compensation Expert Fraud Goals Governance Hedging Incentive Independence Independent Innovation Innovative Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Purpose R&D Reputation Reputational Research and Development Responsibility Responsible Special Meeting Stewardship Strategy Sustainability Sustainable Targets Tax Tenure Transparency

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On May 25, 2022, Yield10 Bioscience, Inc.(the "Company") held its 2022 annual meeting of its stockholders (the "Annual Meeting"). As of March 28, 2022, the record date for the Annual Meeting, there were 4,893,403 shares of the Company’s common stock outstanding and entitled to vote. At the Annual Meeting, the holders of 3,555,810 shares of the Company’s common stock were present or represented by proxy, which represented 72.7% of the total shares entitled to vote at the Annual Meeting.
A summary of the matters voted upon by the stockholders at the Annual Meeting, each of which is described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 29, 2022, and the final voting results for each matter are set forth below.
Proposal 1 - Election of Directors:
Stockholders reelected the nominees identified below as Class I directors of the Company to hold office until the annual meeting of stockholders in 2025 and until their successors are elected and qualified, subject to their earlier death, resignation or removal. The voting results for the nominees were as follows:

Name of Class I Director Nominees	Votes For	Votes Withheld	Broker Non-Votes

Robert L. Van Nostrand	2,311,380	11,475	1,232,955
Sherri M. Brown	2,316,115	6,740	1,232,955

Proposal 2 - Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm:
The selection of RSM US LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified, based on the following votes:


Votes For	Votes Against	Abstentions
3,548,217	3,781	3,812